Comprehensive CMC Expertise
At InnoTech BioPharm, we collaborate with biotech startups, mid-size pharmaceutical firms, and CROs/CDMOs/CMOs to bring innovative drug products to market with unparalleled precision, speed, and cost efficiency.
Our tailored CMC strategies ensure that your biopharmaceutical innovations meet global regulatory standards while optimizing cost-efficiency, compliance, and commercial scalability.
Our expertise spans multiple pharmaceutical modalities, including:- Small Molecules – Formulation development of complex drug delivery systems, stability, process innovation, and scale-up.
- Biologics – Advanced characterization, process development, and technology transfer for monoclonal antibodies, recombinant proteins, and cell and gene therapies.
- Specialty Injectables – Development of Lipid Nanoparticles (LNPs) for Nucleic Acid delivery, Long-Acting Injectables and sterile drug formulations.
- Microparticles, Liposomes, In Situ Forming Gels, Oil based Solutions & Suspensions, and Nanoparticles
- Highly Potent APIs (HPAPIs) – Expertise in safe handling, formulation development, and scale-up of highly potent and cytotoxic compounds.
Whether you’re preparing for your first-in-human (FIH) trials or a commercial launch, our science-driven approach and regulatory expertise ensure that your development program is seamless, compliant, fast, and cost efficient.